CN104304293A - Method for preventing and treating anthracnose of orchid - Google Patents

Method for preventing and treating anthracnose of orchid Download PDF

Info

Publication number
CN104304293A
CN104304293A CN201410556073.9A CN201410556073A CN104304293A CN 104304293 A CN104304293 A CN 104304293A CN 201410556073 A CN201410556073 A CN 201410556073A CN 104304293 A CN104304293 A CN 104304293A
Authority
CN
China
Prior art keywords
orchid
anthracnose
preventing
thiophanate methyl
carbendazim
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410556073.9A
Other languages
Chinese (zh)
Inventor
陈财宝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liuzhou Tianzi Horticulture Co Ltd
Original Assignee
Liuzhou Tianzi Horticulture Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liuzhou Tianzi Horticulture Co Ltd filed Critical Liuzhou Tianzi Horticulture Co Ltd
Priority to CN201410556073.9A priority Critical patent/CN104304293A/en
Publication of CN104304293A publication Critical patent/CN104304293A/en
Pending legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention discloses a method for preventing and treating anthracnose of orchid. The method is characterized in that a chemical with an active component consisting of thiophanate methyl and carbendazim is applied to orchid, wherein the mass ratio of thiophanate methyl to carbendazim is (3-1) to 1. Compared with the conventional method, the method has the advantages that the control effect on the anthracnose of the orchid is obviously better.

Description

A kind of method of preventing and treating cymbidium anthracnose
technical field
The present invention relates to a kind of method of preventing and treating cymbidium anthracnose.
Background technology
Cymbidium anthracnose is one of Major Diseases of orchid cultivation, and occurrence scope is quite extensive at home, all can occur throughout the year, especially spring, autumn to fall ill heavier.If disease can not get effective control, final blade is withered gradually from top to bottom, scattered syringe needle shape pore on later stage scab, i.e. the Spreading source that infects again of germ, and reduces ornamental value.
Summary of the invention
The object of this invention is to provide a kind of method of preventing and treating cymbidium anthracnose.
In order to solve the problems of the technologies described above, the invention provides following technical scheme:
Prevent and treat a method for cymbidium anthracnose, use to orchid the medicine that active component is made up of thiophanate methyl and carbendazim, wherein, the mass ratio of described thiophanate methyl and carbendazim is (3-1): 1.
Described medicine contains pharmaceutic adjuvant.Insecticide-applying way can adopt conventional spray pattern.By drug dilution 500-1000 doubly to being applied to orchid.
Embodiment
Below in conjunction with preferred embodiment, the present invention will be described, should be appreciated that preferred embodiment described herein is only for instruction and explanation of the present invention, is not intended to limit the present invention.
Embodiment 1
By 70% commercially available thiophanate methyl wetting powder with 50% carbendazol wettable powder in mass ratio for 1:1 mixes, 900 times of water diluents of this medicament are sprayed at cymbidium anthracnose their early stage, medicine is sprayed 1 time every 7 days, totally 3 times, the total number of sheets of the control efficiency 95%(of 30 days 330 after medication).
Contrast 1: by 70% thiophanate methyl wetting powder dilute with water 800 times, spray dilution at cymbidium anthracnose their early stage, sprayed medicine 1 time every 7 days, totally 4 times, the total number of sheets of the control efficiency 79%(of 30 days 247 after medication).
Contrast 2: after 50% carbendazol wettable powder dilute with water 500 times, spray dilution at cymbidium anthracnose their early stage, sprayed medicine 1 time every 7 days, totally 3 times, the total number of sheets of the control efficiency 25%(of 30 days 150 after medication).
Embodiment 2
By 50% commercially available thiophanate methyl suspending agent with 40% carbendazim suspending agent in mass ratio for 2:1 mixes, its 900 times of water diluents are sprayed at cymbidium anthracnose their early stage, medicine is sprayed 1 time, totally 3 times, the total number of sheets of the control efficiency 96%(of 30 days 300 after medication) every 7 days.
Embodiment 3
By 50% commercially available thiophanate methyl suspending agent with 40% carbendazim suspending agent in mass ratio for 4:5 mixes, its 900 times of water diluents are sprayed at cymbidium anthracnose their early stage, medicine is sprayed 1 time, totally 3 times, the total number of sheets of the control efficiency 93%(of 30 days 280 after medication) every 7 days.
Last it is noted that the foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.

Claims (1)

1. prevent and treat a method for cymbidium anthracnose, use to orchid the medicine that active component is made up of thiophanate methyl and carbendazim, wherein, the mass ratio of described thiophanate methyl and carbendazim is (3-1): 1.
CN201410556073.9A 2014-10-20 2014-10-20 Method for preventing and treating anthracnose of orchid Pending CN104304293A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410556073.9A CN104304293A (en) 2014-10-20 2014-10-20 Method for preventing and treating anthracnose of orchid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410556073.9A CN104304293A (en) 2014-10-20 2014-10-20 Method for preventing and treating anthracnose of orchid

Publications (1)

Publication Number Publication Date
CN104304293A true CN104304293A (en) 2015-01-28

Family

ID=52359731

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410556073.9A Pending CN104304293A (en) 2014-10-20 2014-10-20 Method for preventing and treating anthracnose of orchid

Country Status (1)

Country Link
CN (1) CN104304293A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107646456A (en) * 2017-11-01 2018-02-02 柳州市绿盈庄花卉有限公司 A kind of breeding method for controlling orchid spot

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164582A (en) * 1976-04-13 1979-08-14 Kemira Oy Synergistic fungicidal compositions
CN1353933A (en) * 2001-09-28 2002-06-19 唐永琦 Medicine for silkworm and its preparation method
CN101411280A (en) * 2008-12-12 2009-04-22 唐山师范学院 Method for cultivating Phalaenopsis amabilis Bl. in day-light greenhouse in north area
CN103787785A (en) * 2014-03-06 2014-05-14 郭志红 Crop bactericide additive

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164582A (en) * 1976-04-13 1979-08-14 Kemira Oy Synergistic fungicidal compositions
CN1353933A (en) * 2001-09-28 2002-06-19 唐永琦 Medicine for silkworm and its preparation method
CN101411280A (en) * 2008-12-12 2009-04-22 唐山师范学院 Method for cultivating Phalaenopsis amabilis Bl. in day-light greenhouse in north area
CN103787785A (en) * 2014-03-06 2014-05-14 郭志红 Crop bactericide additive

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
易绮斐 等: "兰花主要病害及其防治", 《植物保护》, vol. 30, no. 1, 8 February 2004 (2004-02-08) *
桂炳中: "多菌灵、苯菌灵和甲基托布津的科学使用", 《科学种养》, 1 February 2008 (2008-02-01), pages 7 - 2 *
赵书梅: "蝴蝶兰炭疽病的发生与防治", 《河北农业科技》, 2 October 2004 (2004-10-02), pages 19 - 1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107646456A (en) * 2017-11-01 2018-02-02 柳州市绿盈庄花卉有限公司 A kind of breeding method for controlling orchid spot

Similar Documents

Publication Publication Date Title
MX2021000609A (en) Methods of treatment with cyp3a4 substrate drugs.
MX2021000148A (en) Heterocyclic inhibitors of erk1 and erk2 and their use in the treatment of cancer.
WO2021050953A8 (en) Compositions and methods for the delivery of therapeutic biologics for treatment of disease
MY201105A (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
MX2015008396A (en) 2,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, and pharmaceutical composition including same.
EA201992862A1 (en) Nasal Drug Forms of Dihydroergotamine
HRP20211824T1 (en) Modulators of complement activity
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
WO2015187998A3 (en) Use of inhibitor of apoptosis protein (iap) antagonists in hiv therapy
MY163235A (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
WO2015058664A8 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
EP4279128A3 (en) Novel antibody binding to tfpi and composition comprising the same
EA033446B1 (en) Heterocyclic compound for treating macular degeneration and/or stargardt's disease
WO2016142708A3 (en) Pharmaceutical composition
WO2016040169A3 (en) Mucolytic agents for use in tretaing pulmonary sarcoidosis
UY37306A (en) COMBINATIONS OF ACTIVE COMPOUNDS
EP3352750A4 (en) Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
PH12019502510A1 (en) Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof
MX2021009219A (en) Triamterene or nolatrexed for use in the treatment of phenylketonuria.
CN104304293A (en) Method for preventing and treating anthracnose of orchid
WO2017030383A3 (en) Pharmaceutical composition for preventing or treating muscular dystrophy including bakuchiol as active ingredient
MY197518A (en) Preventive and/or therapeutic agent of immune disease
CN104351232A (en) Composition for preventing and curing orchid anthracnose
MX2020005310A (en) Combination product comprising dicycloplatin and preparation method and use thereof.
CN104351221A (en) Composition for preventing and treating orchid southern blight

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20150128

RJ01 Rejection of invention patent application after publication